Millennium Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing breakthrough products in the disease areas of cancer, cardiovascular disease and inflammatory disease. The Company operates in one business segment, which focuses on the development and commercialization of proprietary therapeutic products. It has two products on the market, Velcade (bortezomib) for Injection, a cancer product for patients with multiple myeloma, and Integrilin (eptifibatide) Injection, a cardiovascular product that prevents platelet aggregation.